Price target upside
Xenon Pharmaceuticals Inc. - Common Shares Price Target Upside or Downside
XENE price target upside based on the current price and analyst average.
Direct answer
Xenon Pharmaceuticals Inc. - Common Shares's analyst target implies +26.6%.
The average target is $81.30 compared with a recorded current price of $64.23.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 14, 2026.
Get free Xenon Pharmaceuticals Inc. - Common Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $64.23
- Average price target
- $81.30
- High price target
- $100.00
- Low price target
- $69.00
- Target upside
- +26.6%
- Consensus rating
- Strong Buy
- Analysts
- 19
- Evidence date
- August 14, 2026
- Valid through
- August 21, 2026